Bell's Palsy: A Nutrition and Natural-Health Reference
Definition and Overview
Bell's palsy, also known as "acute facial palsy of unknown cause," is a common cranial neuropathy leading to facial muscle paresis or complete paralysis characteristically on one side, occurring suddenly and may progress over 48 hours. Bell's palsy, also called cranial nerve VII or facial nerve palsy, is a sudden-onset facial weakness with several potential triggers. Bell described it as an acute-onset, idiopathic facial paralysis due to a dysfunction anywhere along the peripheral portion of the facial nerve; initially all cases of facial nerve paralysis were called Bell's palsy, but after causes of the disease were discovered, only the idiopathic cases retained that name.
Bell's palsy is named after Sir Charles Bell (1774β1842), who first described the syndrome along with the anatomy and function of the facial nerve. The annual incidence of Bell's palsy is 15 to 30 per 100,000 persons, with equal numbers of men and women affected, and there is no predilection for either side of the face. About 1.5% of people are affected at some point in their lives, and it most commonly occurs in people between ages 15 and 60.
Body Systems Involved and Anatomy
Bell's palsy results from a problem in the seventh cranial nerve, also called the facial nerve, which connects the brain to the muscles that control facial expression. This idiopathic, acute peripheral-nerve palsy involves the facial nerve, which supplies all the muscles of facial expression; the facial nerve also contains parasympathetic fibers to the lacrimal and salivary glands, as well as limited sensory fibers supplying taste to the anterior two thirds of the tongue.
The precise pathophysiology of Bell's palsy is unclear; research has shown that edema and ischemia can result in the compression of the facial nerve within the canal of the temporal bone, and this compression has been seen in MRI scans with facial nerve enhancement. Injury to the facial nerve in Bell's palsy is peripheral to the nerve's nucleus, and the injury is thought to occur at or near the geniculate ganglion. If the lesion is proximal to the geniculate ganglion, the motor paralysis is accompanied by gustatory and autonomic abnormalities; lesions between the geniculate ganglion and the origin of the chorda tympani produce the same effect, except that they spare lacrimation.
The facial nerve is derived from the second branchial arch, which also gives rise to the muscles of the face, the occipitofrontalis muscle, the platysma, the stylohyoid muscle, the posterior belly of the digastric muscle, the stapedius muscle, and the auricular muscles β all innervated by the facial nerve β and the nerve also controls salivary and lacrimal glands.
The widely accepted mechanism is inflammation of the facial nerve during its course through the bony labyrinthine part of the facial canal, which leads to compression and demyelination of the axons, and disruption of blood supply to the nerve itself.
Clinical Presentation
Affected patients develop unilateral facial paralysis over one to three days with forehead involvement and no other neurologic abnormalities; symptoms typically peak in the first week and then gradually resolve over three weeks to three months. Symptoms appear suddenly over a 48- to 72-hour period and generally begin to improve after a few weeks; the symptoms vary from person to person and can be mild to severe.
Although defined as a mononeuritis involving only one nerve, people diagnosed with Bell's palsy may have "myriad neurological symptoms," including "facial tingling, moderate or severe headache/neck pain, memory problems, balance problems, ipsilateral limb paresthesias, ipsilateral limb weakness, and a sense of clumsiness" that are "unexplained by facial nerve dysfunction."
Bell's palsy raises important aesthetic and psychological issues because it involves the ability to express emotion by controlling the position of the mouth, nostrils, and eyebrows, and to control eye closure, drooling, and speech.
People with Bell's palsy usually recover some or all facial function within a few weeks to six months; sometimes, the facial weakness may last longer or be permanent. Recovery happens in about 80% of cases; for others, facial weakness can be long-lasting, and the longer the recovery, the more likely lasting issues will occur.
Etiology and Contributing / Associated Factors
Viral Etiology
The exact cause of Bell's palsy remains uncertain, with several potential contributing factors suggested, including viral infections, nerve ischemia, immune-mediated inflammation, and hereditary factors; viral etiologies have gained wider acceptance due to the isolation of the herpes simplex virus type 1 genome from the saliva and endoneurial fluid of affected individuals.
A well-controlled study provided conclusive evidence that reactivation of HSV genomes from the geniculate ganglia is the most important cause of Bell's palsy; Bell's palsy, defined as idiopathic peripheral facial paralysis of sudden onset, accounts for more than 50% of all cases of facial paralysis. Previous studies have suggested viral infection as the etiology of the disease based on serological evidence; for example, positive serology for herpes simplex virus (HSV) has been reported in 20β79% of patients.
The infection is said to be latent when there is no active viral replication, but in the presence of antibodies or immunodeficient states, nerve damage and inflammation of the facial nerve may occur; other viruses known to be involved in the causation of Bell's palsy include Epstein-Barr virus causing infectious mononucleosis, cytomegalovirus, adenovirus, mumps virus, and influenza B.
Some research suggests that herpes viruses might participate in the complex mechanisms of autoimmunity of Bell's palsy but not as a determinant etiological element.
Inflammatory and Immune Mechanisms
The cause of Bell's palsy is not definitively known; it is thought that it may be due to inflammation that is directed by the body's immune system against the nerve controlling movement of the face. High cytokine levels (IL-6, IL-8, and TNF-Ξ±) have been observed in Bell's palsy patients, suggesting these cytokines may represent a pathological immune response or may themselves be pathogenetic factors.
Metabolic and Vascular Risk Factors
Risk factors for Bell's palsy include pregnancy, preeclampsia, obesity, hypertension, diabetes, and upper respiratory ailments. Several factors associated with Bell's palsy have been reported, including hypertension, diabetes, and dyslipidemia, which are associated with microangiopathy and can be risk and prognostic factors for Bell's palsy.
Vascular ischemia may be primary, secondary, or tertiary; primary ischemic neuropathy, which causes inflammation of the afflicted nerve, is more prone to take place in specific clinical circumstances such as diabetes mellitus, and is usually induced by cold or emotional stress.
Its etiology remains largely unknown, though risk factors such as herpes simplex virus reactivation, diabetes, depression, and pregnancy-related complications have been suggested. Herpes simplex virus reactivation appears to be a major risk factor, suggesting a potential role of antiviral therapies in select cases; the associations with diabetes and depression highlight a need for metabolic and mental health evaluations in patients with Bell's palsy.
Pregnancy
Pregnant women are affected 3.3 times more often than non-pregnant women, and Bell's palsy presents almost exclusively in the third trimester of pregnancy or puerperium; infection, immunosuppression, and ischaemic mechanisms are all potential factors for the development of Bell's palsy, but the exact causes remain inconclusive. Edema in late pregnancy with secondary compression of the facial nerve in the Fallopian canal, herpes simplex virus reactivation in the facial nerve with secondary nerve damage, and pregnancy-related hypercoagulopathy have all been considered as possible etiologies.
Immunity, Stress, and Sleep
Impaired immunity due to stress, sleep deprivation, physical trauma, minor illness, or autoimmune syndromes is cited as a pathway associated with Bell's palsy onset. Researchers think the source of this dysfunction may be due to inflammation of the seventh cranial nerve; this inflammation may be related to a viral infection or lowered immunity due to stress, lack of sleep, or illness, and swelling puts pressure on the nerve and restricts blood and oxygen from moving to the nerve cells.
Nutritional Status as a Prognostic Factor
Research indicates that immune and nutritional condition play important roles in the pathogenesis of Bell's palsy, suggesting that immune-nutritional status (INS) would be one of the useful prognostic factors in Bell's palsy. Immune-nutritional status calculated from peripheral blood examination has been reported as a prognostic factor in various diseases, though its validity specifically as a prognostic factor in Bell's palsy was not well known at the time of the study.
Nutrients, Herbs, and Natural Ingredients
Vitamin B12 (Cobalamin / Methylcobalamin)
Rationale
Vitamin B12 is essential for the synthesis and maintenance of myelin, the insulating sheath that surrounds peripheral nerves including the facial nerve. Vitamin B12 is currently used clinically for peripheral nerve damage. Demyelination is a recognized mechanism of injury in Bell's palsy, and B12-dependent myelin repair is the basis for its proposed relevance.
Scientific Evidence
Sixty patients with Bell's palsy were included in an open randomized trial; patients were assigned into three treatment groups: steroid (group 1), methylcobalamin (group 2), and methylcobalamin plus steroid (group 3), and comparison between the three groups was based on the number of days needed to attain full recovery, facial nerve scores, and improvement of concomitant symptoms.
The time required for complete recovery of facial nerve function was significantly shorter (p < 0.001) in the methylcobalamin group (mean of 1.95 Β± 0.51 weeks) and methylcobalamin plus steroid group (mean of 2.05 Β± 1.23 weeks) than in the steroid group (mean of 9.60 Β± 7.79 weeks); the facial nerve score after 1β3 weeks of treatment was significantly more severe in the steroid group compared to the methylcobalamin and methylcobalamin plus steroid groups, and improvement of concomitant symptoms was better in the methylcobalamin-treated groups.
However, a commentary in the American Family Physician noted this study has several methodologic flaws: it was not randomized or blinded, and the group that received prednisone had a mean recovery time of 9.6 weeks β well beyond the roughly three weeks reported in many other large trials even with no treatment β suggesting this group may have contained more severe cases; the standard deviations for the control and prednisone arms were well over 50% of the mean recovery times reported, suggesting the study was poorly powered.
A meta-analysis found that in patients with Bell's palsy, acupuncture combined with vitamin B12 can reduce the risk of incomplete recovery compared with acupuncture alone; however, because of study bias and methodological limitations, this conclusion is uncertain and clinical application requires further exploration. Previous trials comparing the effect of vitamin B12 and methylcobalamin showed that the benefit of methylcobalamin was greater than the benefit of vitamin B12 in patients with Bell's palsy.
Despite promising results, the overall evidence quality is moderate, and not all clinical guidelines recommend B12 supplementation due to variability in study results and the need for further large-scale, high-quality trials.
B-Vitamin Complex (B1, B6, B12)
The two most prevalent mononeuropathies are Bell's palsy, which affects the facial nerve and results in facial paralysis, and carpal tunnel syndrome; vitamin B12 insufficiency, alongside diabetes, thyroid dysfunctions, alcoholism, chemotherapy, and HIV infection, is among the most frequent causes of polyneuropathy. The co-involvement of B vitamins in peripheral nerve health has led to their combined use in neuropathy protocols. Oral supplementation with alpha-lipoic acid, curcumin phytosome, and B vitamins administered before and after surgery has been reported as safe and effective in patients with carpal tunnel syndrome scheduled for surgical decompression of the median nerve. No comparable high-quality human trial specifically studying combined B-vitamin supplementation for Bell's palsy was identified in the peer-reviewed literature.
Alpha-Lipoic Acid (ALA)
Alpha-lipoic acid (ALA) is a bioactive molecule with significant health effects. Alpha-lipoic acid, a free radical-scavenging nutrient involved in glucose and fat metabolism, is used to treat metabolic disorders like obesity and diabetes, as well as neurological complications such as diabetic neuropathy. Its relevance to Bell's palsy is theoretical, based on its role in peripheral nerve protection. Animal research has investigated ALA in models of facial nerve injury, but no dedicated, blinded human clinical trials specifically for Bell's palsy and ALA had been identified in the peer-reviewed literature at the time of this writing.
Zinc
Traditional Use
Zinc has not been attributed a specific traditional-medicine application for facial palsy in classical herbalism. Its historical use has been primarily topical (wound healing) and general nutritional, with more modern interest arising from its immunological and antiviral properties.
Scientific Evidence
Zinc is an important nutrient for normal nerve function, and deficiency can cause hearing and taste disturbances and contribute to depression and neurological disorders; zinc supports nerve growth and the formation of new neuronal connections, and it also inhibits the replication of HSV-1 and has been effectively used in multiple clinical trials to reduce the duration of herpes outbreaks. Zinc deficiency can impair the ability of nerves to transmit signals. No dedicated clinical trial of zinc supplementation specifically for Bell's palsy was identified in the peer-reviewed literature; the evidence for zinc's relevance to Bell's palsy is indirect, based on its established anti-HSV and neuroprotective properties in other contexts.
L-Lysine
Traditional Use
L-lysine as a specific intervention for herpes-related conditions is a modern nutritional approach, not a traditional herbal practice. Its use derives from observed competitive antagonism with arginine in herpes virus replication.
Scientific Evidence
Lysine is an amino acid sometimes used to treat recurrent herpes simplex infections; it has not been formally evaluated in the context of Bell's palsy, but studies have found it to be useful in combating herpes virus-related illnesses. A double-blind, placebo-controlled study that included participants with oral-facial or genital herpes found that consumption of one gram of L-lysine three times daily for six months reduced the frequency, duration, and severity of herpes outbreaks. The proposed mechanism connecting L-lysine to Bell's palsy is entirely indirect β through inhibition of HSV reactivation β and no human trial has directly assessed L-lysine for Bell's palsy. Evidence in this context is therefore preliminary and inferential.
Omega-3 Fatty Acids
Traditional Use
Omega-3-rich foods such as fatty fish and flaxseed have been components of traditional diets in numerous cultures, but their specific use for facial paralysis is not documented in classical herbal traditions.
Scientific Evidence
Omega-3 fatty acids like eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are converted into anti-inflammatory compounds that can help protect nerves from damage. Their proposed relevance to Bell's palsy is based on the significant inflammatory component of the condition and the general neuroprotective profile of EPA and DHA in peripheral neuropathy research. No dedicated human trial for Bell's palsy and omega-3 supplementation was identified in the peer-reviewed literature at the time of writing; the evidence is mechanistically plausible but currently limited to indirect support.
Glycyrrhiza glabra (Licorice / Glycyrrhizin)
Traditional Use
Licorice (Glycyrrhiza glabra) has been used traditionally to combat viral infections. In traditional Chinese medicine, licorice root (gancao) is a foundational harmonizing herb present in numerous classical formulas and is used for a broad range of conditions, including those involving inflammation and immune modulation.
Scientific Evidence
Licorice contains compounds that exert strong anti-inflammatory effects and have demonstrated antiviral activity against several viruses, including HSV-1 and varicella zoster virus, in preclinical studies. The compound glycyrrhizin, found in licorice, is recognized for its potent anti-inflammatory, antioxidant, antiviral, and neuroprotective bioactivities. No high-quality human clinical trial has specifically examined licorice or isolated glycyrrhizin for Bell's palsy. Evidence remains at the preclinical and mechanistic level.
Black Seed (Nigella sativa) and Thymoquinone
Traditional Use
Nigella sativa seed (black seed, black cumin) has been used medicinally for centuries across North African, Middle Eastern, and South Asian traditions for a diverse range of conditions including inflammatory and infectious diseases.
Scientific Evidence
Thymoquinone, the principal bioactive compound of black seed, is known for its potent anti-inflammatory, antioxidant, antiviral, and neuroprotective bioactivities, which has led to its conceptual application in Bell's palsy treatment regimens. Current clinical evidence specific to Bell's palsy is absent from the high-quality peer-reviewed literature; the rationale rests on these general pharmacological properties.
Curcumin (from Curcuma longa, Turmeric)
Traditional Use
Turmeric has been a central medicinal and culinary plant in Ayurvedic and traditional Chinese medicine for over two millennia, used for inflammatory conditions, wound healing, and neurological complaints.
Scientific Evidence
Curcumin, the principal bioactive compound from turmeric, is known for its potent anti-inflammatory, antioxidant, antiviral, and neuroprotective bioactivities, which have been proposed as potentially useful in addressing the inflammatory and nerve-recovery aspects of Bell's palsy. Combined supplementation with alpha-lipoic acid, curcumin phytosome, and B vitamins has been studied for peripheral nerve compression conditions, providing some indirect evidence for its role in nerve repair contexts. No dedicated, adequately powered clinical trial for curcumin specifically in Bell's palsy was identified in the peer-reviewed literature at the time of writing.
Ganoderma lucidum (Reishi Mushroom)
Traditional Use
Reishi mushroom (Ganoderma lucidum, known as lingzhi in Chinese) has been used for over two thousand years in East Asian traditional medicine as a tonic for immune function, longevity, and resistance to disease.
Scientific Evidence
Reishi mushroom has been listed among natural agents potentially inhibitory to herpes viruses and suggested as potentially supportive in Bell's palsy management. Evidence is largely preclinical (in vitro and animal studies); no human clinical trials for reishi in Bell's palsy were identified in the peer-reviewed literature. This classification of evidence is preliminary.
Acupuncture
Traditional Use
According to Traditional Chinese Medicine (TCM), facial paralysis is known as "deviated mouth" and was attributed to "wind" by past dynasties. Deficiency of "qi" was held to allow the invasion of exogenous pathogenic wind; acupuncture is part of TCM and dates back thousands of years.
Scientific Evidence
Fourteen randomized controlled trials involving 1,541 individuals were included in one systematic meta-analysis; a significant association was observed with acupuncture showing a higher effective response rate for Bell's palsy (relative risk, 1.14; 95% CI, 1.04β1.25; P = 0.005), but there was high heterogeneity among the studies (IΒ² = 87%), and an assessment revealed a high risk of bias in methodological quality. The reviewers concluded that acupuncture seems to be an effective therapy for Bell's palsy, but there was insufficient evidence to support the efficacy and safety of acupuncture definitively.
Another meta-analysis found acupuncture treatment was associated with an increased cure rate (RR = 1.77, 95% CI: 1.41β2.21) and significant difference in total effective rate (RR = 1.18, 95% CI: 1.07β1.31) compared to drugs, but with substantial heterogeneity (IΒ² = 67% and IΒ² = 90%, respectively). Results showed acupuncture was associated with increased cure rate and total effective rate of treatment for Bell's palsy in comparison with drugs; however, the results should be interpreted cautiously because of the poor quality and heterogeneity of the included studies.
A previous Cochrane Systematic Review was unable to make any conclusion about the efficacy of acupuncture for Bell's palsy because of the poor quality of the included studies.
Dietary and Lifestyle Factors
Overall Nutritional Status
Research indicates that immune and nutritional condition play important roles in the pathogenesis of Bell's palsy, and immune-nutritional status may be a useful prognostic factor in the condition. This is supported by the principle that peripheral nerve repair demands adequate nutritional substrate β including B vitamins, protein, antioxidants, and essential fatty acids β regardless of underlying cause.
Metabolic Health: Diabetes, Dyslipidemia, and Obesity
Bell's palsy is more common in patients with diabetes. Hypertension, diabetes, and dyslipidemia, which are associated with microangiopathy, can be risk and prognostic factors for Bell's palsy; these are characteristic of metabolic syndrome, which is a chronic metabolic condition. Dietary patterns that support glycemic control, blood pressure management, and healthy lipid profiles are therefore contextually relevant.
Arginine-to-Lysine Dietary Ratio in Herpes Context
Given the literature linking Bell's palsy to HSV-1 reactivation, some researchers have noted the relevance of the dietary arginine-to-lysine ratio. Lysine is an amino acid sometimes used to treat recurrent herpes simplex infections; it has not been formally evaluated in the context of Bell's palsy, but studies have found it to be useful in combating herpes virus-related illnesses. Foods high in lysine relative to arginine β such as dairy products, legumes, and fish β are sometimes discussed in this context, though no clinical trial has examined this dietary pattern specifically in Bell's palsy patients.
Stress, Sleep, and Lifestyle
Impaired immunity due to stress, sleep deprivation, physical trauma, minor illness, or autoimmune syndromes is listed by the NINDS as a condition associated with the development of Bell's palsy. These factors are mechanistically relevant because HSV reactivation β the most strongly suspected cause β is known to be triggered by immunosuppressive states. This inflammation may be related to a viral infection or lowered immunity due to stress, lack of sleep, or illness, and swelling puts pressure on the nerve and restricts blood and oxygen from moving to the nerve cells.
Upper Respiratory Infections
Risk factors can include pregnancy (especially the third trimester and first week after giving birth), preeclampsia, obesity, high blood pressure, diabetes, autoimmune diseases, and upper respiratory infections like a cold or influenza. Dietary and lifestyle measures that support immune resilience β such as adequate vitamin C and D intake, sleep hygiene, and stress management β are discussed in this context, though direct causative intervention trials in Bell's palsy remain lacking.
Physical Therapy and Adjunct Approaches
Physical therapy, facial massage, or acupuncture may provide some improvement in facial nerve function and pain. In traditional Korean medicine, Bell's palsy is managed across multiple specialties, including acupuncture and herbal medicine in Traditional Korean Medicine, with comparative studies evaluating treatment outcomes across conventional and traditional approaches.
Summary of Evidence Quality
- Methylcobalamin (Vitamin B12): Single open randomized trial with significant methodological limitations (not blinded, potentially unbalanced groups); meta-analyses of acupuncture combined with B12 are limited by study quality. Evidence is preliminary to moderate; not a universal standard of care.
- Zinc: No dedicated Bell's palsy clinical trial. Evidence is indirect, based on anti-HSV activity and neuroprotective roles demonstrated in other conditions.
- L-Lysine: Studied for herpes outbreaks generally, but never directly in Bell's palsy. Evidence is inferential.
- Omega-3 Fatty Acids: Anti-inflammatory and neuroprotective roles established in other contexts; no direct Bell's palsy trial identified. Evidence is mechanistically plausible, preliminary.
- Licorice / Glycyrrhizin: Preclinical antiviral data against HSV-1; no human Bell's palsy trial. Evidence is in vitro/preclinical only.
- Curcumin / Turmeric: Preclinical anti-inflammatory and neuroprotective data; no dedicated human Bell's palsy trial. Evidence is indirect and preliminary.
- Reishi Mushroom: Preclinical antiviral data; no clinical Bell's palsy trial. Evidence is in vitro/preclinical only.
- Black Seed / Thymoquinone: Pharmacological properties proposed; no human Bell's palsy trial. Evidence is mechanistic/conceptual only.
- Acupuncture: Multiple RCTs and systematic reviews; positive signals but high risk of bias and heterogeneity; Cochrane review inconclusive. Evidence is mixed, low-to-moderate quality.
References
- National Institute of Neurological Disorders and Stroke (NINDS): Bell's Palsy
- American Academy of Family Physicians (AAFP): Bell's Palsy: Diagnosis and Management
- Singh A, Deshmukh P. Bell's Palsy: A Review. Cureus. 2022. PMC9648613
- Bell's Palsy: Description, Diagnosis, and Current Management. PMC11835628
- Bell's palsy: data from a study of 70 cases. PMC4391366
- Murakami S et al. Bell's palsy and herpes simplex virus. PubMed 9393551
- Bell's palsy in pregnancy: A scoping review of risk factors, treatment and outcomes. PMC10601580
- Association between hypertensive disorders and Bell's palsy in pregnancy: protocol for a systematic review. PMC11103191
- Risk factors for Bell's palsy based on Korean National Health Insurance Service data. PMC8642421
- Risk Factors Associated With Bell's Palsy: A Real-World Analysis of 281,600 Patients. PMC12368598
- Jalaludin MA. Methylcobalamin treatment of Bell's palsy. Methods Find Exp Clin Pharmacol. 1995. PubMed 8749227
- AAFP: Treatment Options for Patients with Bell's Palsy (commentary on methylcobalamin study)
- Acupuncture and vitamin B12 injection for Bell's palsy: no high-quality evidence exists. PMC4468776
- Efficacy of Acupuncture for Bell's Palsy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PMC4431843
- Compare the efficacy of acupuncture with drugs in the treatment of Bell's palsy: A systematic review and meta-analysis. PMC6531040
- Acupuncture for Bell's palsy (Cochrane-related review). PMC7133542
- Antiviral treatment for Bell's palsy (idiopathic facial paralysis). PMC6726970
- Corticosteroid and antiviral therapy for Bell's palsy: A network meta-analysis. PMC3025847
- Immune-Nutritional Status as a Novel Prognostic Predictor of Bell's Palsy. PubMed 35512660
- Vitamin C Deficiency as a Risk Factor for Bell's Palsy: A New Association. PMC8831488
- Alpha-Lipoic Acid: Biological Mechanisms and Health Benefits. PMC11505271
- Potential Clinical Benefits of Combination of Black Seed, Licorice, and Turmeric Supplements within the Treatment Regimens of Bell's Palsy. Journal of Biomedical Research and Environmental Sciences.
- Recovery and Recurrence in Bell's Palsy: A Propensity Score-Matched Comparative Study Across ENT, Pain Medicine, and Traditional Korean Medicine. PMC12298506
- Medscape: Bell Palsy: Background, Epidemiology, Etiology
- Johns Hopkins Medicine: Bell's Palsy
- American Brain Foundation: Bell's Palsy
- Efficacy of Combination and Single Therapy in Bell's Palsy: A Systematic Review and Meta-Analysis. PMC12476236
Go back